The Wang group (Zhang et al., 2017) investigated whether oncolytic adenovirus delivery of TSLC1 specifically to cancer stem cells (CSCs) of hepatocellular carcinoma (HCC) could impact tumor progression. The gene discussed is CADM1; the disease is hepatocellular carcinoma.